TRANSIENT BLEOMYCIN-INDUCED THROMBOCYTOPENIA - CLINICAL-STUDY

被引：10

作者：

HILGARD, P ^{[1
]}

HOSSFELD, DK ^{[1
]}

机构：

[1] UNIV ESSEN GESAMTHSCH,INNERE TUMORFORSCH KLIN,ZENTRUM WESTDEUTSCHES TUMOR,D-4300 ESSEN,FED REP GER

来源：

关键词：

D O I：

10.1016/0014-2964(78)90233-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1261 / 1264

页数：4

共 17 条

[1]

ADAMSON IYR, 1974, AM J PATHOL, V77, P185

[2]

AGRE KA, 1974, NEW DRUG SEMINAR BLE

[3]

ASHFORD TP, 1968, AM J PATHOL, V53, P599

[4]

BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO

[5]

2-N

[6] QUANTITATIVE ASSAY OF FACTOR 13 WITH ANTI-FACTOR 13 SERUM [J].

BOHN, H ;

HAUPT, H .

THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1968, 19 (3-4) :309-&

BRADLEY, J ;

HICKMAN, JA .

[8] BLEOMYCIN LUNG [J].

BURKHARDT, A ;

GEBBERS, JO ;

HOLTJE, WJ .

[9]

Dacie JV., 1991, PRACTICAL HAEMATOLOG

[10]

DECONTI RC, 1975, CATHARANTHUS ALKALOI, P237